SI1727817T1 - Azabiciklooktan-3-onski derivati in njihova uporaba - Google Patents

Azabiciklooktan-3-onski derivati in njihova uporaba

Info

Publication number
SI1727817T1
SI1727817T1 SI200531186T SI200531186T SI1727817T1 SI 1727817 T1 SI1727817 T1 SI 1727817T1 SI 200531186 T SI200531186 T SI 200531186T SI 200531186 T SI200531186 T SI 200531186T SI 1727817 T1 SI1727817 T1 SI 1727817T1
Authority
SI
Slovenia
Prior art keywords
azabicyclooctan
derivatives
compounds
formula
cancer
Prior art date
Application number
SI200531186T
Other languages
English (en)
Inventor
Jacob Westman
Klas Wiman
Galina Selivanova
Vladimir Bykov
Original Assignee
Aprea Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aprea Ab filed Critical Aprea Ab
Publication of SI1727817T1 publication Critical patent/SI1727817T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SI200531186T 2004-03-22 2005-03-22 Azabiciklooktan-3-onski derivati in njihova uporaba SI1727817T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0400708A SE0400708D0 (sv) 2004-03-22 2004-03-22 New compounds and use thereof
PCT/SE2005/000412 WO2005090341A1 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof
EP05722253A EP1727817B1 (en) 2004-03-22 2005-03-22 Azabicyclooctan-3-one derivatives and use thereof

Publications (1)

Publication Number Publication Date
SI1727817T1 true SI1727817T1 (sl) 2011-01-31

Family

ID=32067464

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531186T SI1727817T1 (sl) 2004-03-22 2005-03-22 Azabiciklooktan-3-onski derivati in njihova uporaba

Country Status (15)

Country Link
US (1) US7759361B2 (sl)
EP (1) EP1727817B1 (sl)
JP (1) JP4904561B2 (sl)
AT (1) ATE482955T1 (sl)
AU (1) AU2005223728B2 (sl)
CA (1) CA2552855C (sl)
CY (1) CY1111256T1 (sl)
DE (1) DE602005023840D1 (sl)
DK (1) DK1727817T3 (sl)
ES (1) ES2349471T3 (sl)
PL (1) PL1727817T3 (sl)
PT (1) PT1727817E (sl)
SE (1) SE0400708D0 (sl)
SI (1) SI1727817T1 (sl)
WO (1) WO2005090341A1 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062030A2 (en) * 2005-11-21 2007-05-31 Ohio University Quinuclidinone derivatives as anticancer agents
AU2011208681B2 (en) 2010-01-21 2014-10-23 Aprea Therapeutics Ab Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
CN104860994A (zh) * 2014-02-20 2015-08-26 中国药科大学 3-奎宁环酮类含磷化合物的制备及其医药用途
WO2017159877A1 (en) * 2016-03-18 2017-09-21 Eisai R&D Management Co., Ltd. Use of eribulin and 3-quinuclidinone derivatives in the treatment of cancer
CN109280056A (zh) * 2017-07-21 2019-01-29 上海时莱生物技术有限公司 手性3-奎宁环酮类化合物、制备方法及用途
CN109280054A (zh) * 2017-07-21 2019-01-29 上海时莱生物技术有限公司 氘代3-奎宁环酮类化合物、制备方法及用途
JP2022500471A (ja) 2018-09-20 2022-01-04 アプレア セラピューティクス アクティエボラーグ キヌクリジン−３−オン化合物および癌治療へのその使用
US20220339141A1 (en) 2019-09-18 2022-10-27 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of an antiapoptotic bcl-2 family protein
WO2021170772A1 (en) 2020-02-26 2021-09-02 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of cd47 mediated signaling
WO2021180338A1 (en) 2020-03-09 2021-09-16 Aprea Therapeutics Ab Combination treatment with a p53 reactivator and an inhibitor of dna methyltransferase post stem cell transplant
WO2022175402A1 (en) 2021-02-18 2022-08-25 Aprea Therapeutics Ab Quinuclidine-3-one derivatives
WO2022204109A1 (en) * 2021-03-22 2022-09-29 Newave Pharmaceutical Inc. Quinuclidinone analogues as anticancer agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384641A (en) * 1967-09-19 1968-05-21 Aldrich Chem Co Inc 2-methylene-3-quinuclidones
US3726877A (en) * 1970-10-28 1973-04-10 Univ Temple Amine substituted methylene quinuclidone anti-bacterial agents
US4599344A (en) * 1984-10-31 1986-07-08 Schering A.G. Quinuclidines and quinuclidinium salts as antiarrhythmic agents
ATE113947T1 (de) * 1990-06-01 1994-11-15 Pfizer 3-amino-2-arylchinuclidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
US6953855B2 (en) * 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US6432975B1 (en) * 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
AU2001282875A1 (en) * 2000-08-21 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
CA2423192C (en) 2000-09-20 2010-11-23 Karolinska Innovations Ab 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
WO2003070250A1 (en) * 2002-02-21 2003-08-28 Aprea Ab Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases
SE0300812D0 (sv) 2003-03-24 2003-03-24 Karolinska Innovations Ab Use of chemical compounds for preparing pharmaceutical compositions, and method of testing substances for medical effect
CA2519795A1 (en) * 2003-03-24 2004-10-07 Aprea Ab Pharmaceutical use of 1-azabicyclo[2.2.2]octanes and a method of testing compounds for the ability of activating inactive wt p53

Also Published As

Publication number Publication date
WO2005090341A1 (en) 2005-09-29
ATE482955T1 (de) 2010-10-15
JP2007530534A (ja) 2007-11-01
JP4904561B2 (ja) 2012-03-28
CA2552855C (en) 2012-08-14
US7759361B2 (en) 2010-07-20
EP1727817A1 (en) 2006-12-06
EP1727817B1 (en) 2010-09-29
DE602005023840D1 (de) 2010-11-11
AU2005223728A1 (en) 2005-09-29
CA2552855A1 (en) 2005-09-29
PT1727817E (pt) 2010-10-26
PL1727817T3 (pl) 2011-03-31
ES2349471T3 (es) 2011-01-03
SE0400708D0 (sv) 2004-03-22
US20070142370A1 (en) 2007-06-21
AU2005223728B2 (en) 2011-02-10
CY1111256T1 (el) 2015-08-05
DK1727817T3 (da) 2011-01-10

Similar Documents

Publication Publication Date Title
PL1727817T3 (pl) Pochodne azabicyklooktan-3-onu i ich zastosowanie
TW200613243A (en) Novel compounds
SE0200920D0 (sv) Novel compounds
SE0202539D0 (sv) Compounds
TW200616995A (en) Novel compounds
TW200626553A (en) Novel compounds
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MX2007003031A (es) Compuestos heteroarilo para uso como betamimeticos en el tratamiento de enfermedades de vias respiratorias.
MY143565A (en) Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof
EP2966065A3 (en) Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
IL184872A0 (en) Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
IL185063A0 (en) Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
TW200724537A (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
IS7965A (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
MY150059A (en) Pyrrolo [2,3-d] pyrimidin derivatives as protein kinase b inhibitors
SE0300480D0 (sv) Novel compounds
WO2005115470A3 (fr) COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE β-­CARBOLINE, ET LEUR UTILISATION POUR LE TRAITEMENT DES CANCERS
GB0112348D0 (en) Compounds
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
PL1758852T3 (pl) Podstawione związki cyklopentenu
TW200605888A (en) Novel compounds
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
TW200639156A (en) New compounds